Data gathered: July 26
Alternative Data for Kezar Life Sciences
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 2 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 4,000 | Sign up | Sign up | Sign up |
| Employee Rating | 81 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | 17 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | N/A | Sign up | Sign up | Sign up |
| Facebook Followers | 177 | Sign up | Sign up | Sign up |
| Instagram Followers | 194 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,762 | Sign up | Sign up | Sign up |
| Twitter Followers | 504 | Sign up | Sign up | Sign up |
| Twitter Mentions | 9 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 42 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 63 | Sign up | Sign up | Sign up |
| Linkedin Employees | 71 | Sign up | Sign up | Sign up |
About Kezar Life Sciences
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States.
| Price | $0.67 |
| Target Price | Sign up |
| Volume | 132,500 |
| Market Cap | $48M |
| Year Range | $0.55 - $1.05 |
| Dividend Yield | 0% |
| Industry | Biotechnology |
In the news
 |
HC Wainwright Lowers Kezar Life Sciences (NASDAQ:KZR) Price Target to $7.00July 23 - ETF Daily News |
Kezar Life Sciences price target lowered by $13 at H.C. Wainwright, here's whyJuly 21 - Thefly.com |
|
 |
Financial Comparison: Kezar Life Sciences (NASDAQ:KZR) versus Viking Therapeutics (NASDAQ:VKTX)July 19 - ETF Daily News |
 |
Kezar Life Sciences (NASDAQ:KZR) Trading 2.4% HigherJuly 16 - ETF Daily News |
 |
Financial Contrast: Kezar Life Sciences (NASDAQ:KZR) vs. Purple Biotech (NASDAQ:PPBT)June 25 - ETF Daily News |
Kezar Life Sciences : Failure to Satisfy Listing Rule Form 8 KJune 4 - Finnhub |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '24 | 0 | 6.5M | -6.9M | -22M | -23M | -0.300 |
| Q4 '23 | -5.4M | 14M | -14M | -32M | -28M | -0.440 |
| Q3 '23 | 6.6M | 8.8M | -2.2M | -23M | -26M | -0.320 |
| Q2 '23 | 0 | 5.8M | -6.2M | -24M | -24M | -0.340 |
| Q1 '23 | 0 | 6.2M | -6.6M | -22M | -22M | -0.310 |
Insider Transactions View All
| Morningside Venture Investments Ltd filed to sell 5,447,993 shares at $6.9. February 7 '23 |
| Morningside Venture Investments Ltd filed to sell 5,487,993 shares at $7.1. February 7 '23 |
| Morningside Venture Investments Ltd filed to sell 5,512,993 shares at $7.2. February 3 '23 |
| Morningside Venture Investments Ltd filed to sell 5,562,993 shares at $7. February 3 '23 |
| Morningside Venture Investments Ltd filed to sell 5,602,993 shares at $7.1. February 1 '23 |
Similar companies
Read more about Kezar Life Sciences (KZR) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Kezar Life Sciences?
The Market Cap of Kezar Life Sciences is $48M.
What is the current stock price of Kezar Life Sciences?
Currently, the price of one share of Kezar Life Sciences stock is $0.67.
How can I analyze the KZR stock price chart for investment decisions?
The KZR stock price chart above provides a comprehensive visual representation of Kezar Life Sciences' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Kezar Life Sciences shares. Our platform offers an up-to-date KZR stock price chart, along with technical data analysis and alternative data insights.
Does KZR offer dividends to its shareholders?
As of our latest update, Kezar Life Sciences (KZR) does not offer dividends to its shareholders. Investors interested in Kezar Life Sciences should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Kezar Life Sciences?
Some of the similar stocks of Kezar Life Sciences are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.